Seymour E. Liebman's most recent trade in T2 Biosystems Inc was a trade of 25,000 Restricted Stock Units done . Disclosure was reported to the exchange on Nov. 4, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
T2 Biosystems Inc | Seymour Liebman E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2022 | 115,000 | 115,000 | - | - | Restricted Stock Units | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 73,224 | 235,121 (0%) | 0% | - | Common Stock | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 73,224 | 0 | - | - | Restricted Stock Units | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 77,519 | 77,519 | - | - | Restricted Stock Units | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 32,258 | 161,897 (0%) | 0% | - | Common Stock | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 32,258 | 0 | - | - | Restricted Stock Units | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 73,224 | 73,224 | - | - | Restricted Stock Units | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2021 | 45,454 | 45,454 | - | - | Restricted Stock Units | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2021 | 45,454 | 129,639 (0%) | 0% | - | Common Stock | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2021 | 34,188 | 34,188 | - | - | Restricted Stock Units | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2021 | 34,188 | 84,185 (0%) | 0% | - | Common Stock | |
T2 Biosystems Inc | Seymour E. Liebman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 32,258 | 32,258 | - | - | Restricted Stock Units | |
T2 Biosystems Inc | Seymour E. Liebman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 45,454 | 45,454 | - | - | Restricted Stock Units |